Compare iShares MSCI Taiwan ETF (EWT) vs Intuitive Surgical, Inc. (ISRG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares MSCI Taiwan ETF vs Intuitive Surgical, Inc. — how do they compare? iShares MSCI Taiwan ETF trades at $100.05, while Intuitive Surgical, Inc. trades at $400.76 (market cap $137.76B). The key difference: iShares MSCI Taiwan ETF is trading nearer its 52-week high, Intuitive Surgical, Inc. nearer its low. Which is the better fit depends on your goals.
| EWT | ISRG | |
|---|---|---|
Sector | Broad Market / Factor | Health |
52-Week High | $111.53 | $592.85 |
52-Week Low | $58.05 | $379.50 |
Market Cap | — | $137.76B |
Enterprise Value | — | $133.24B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
The iShares MSCI Taiwan ETF (EWT) trades at $100.08, down 1.77% on the day, consolidating after a significant rally that saw the fund more than double over the past year. Technical indicators show a neutral overall signal with mixed moving average and oscillator readings, while the fund remains strategically positioned at the center of the global AI infrastructure surge through its heavy exposure to Taiwan's semiconductor sector, led by TSMC.
The outlook for EWT is balanced between strong fundamental tailwinds from AI-driven semiconductor demand and significant geopolitical risks related to Taiwan-China tensions. While the fund offers concentrated exposure to a critical technology supply chain, stretched valuations and potential currency headwinds create near-term uncertainty for investors.
Intuitive Surgical (ISRG) trades at $399.75, up 5.34% today, but remains 25% below its 52-week high amid 2026 weakness. The stock shows bearish technical signals with key resistance near $402, while fundamentals remain strong with consistent revenue growth to $10.06B in 2025 and a 28.15% net margin. Recent quarters have seen earnings beats, with Q2 2026 results due July 16. Analyst sentiment is predominantly bullish with a $552.36 price target, though competition concerns persist.
Outlook: Long-term growth prospects in robotic surgery are compelling, supported by da Vinci 5 adoption and AI integration. Near-term risks include margin pressure and competitive threats. The stock offers potential upside if Q2 earnings beat expectations, but volatility may continue until growth catalysts materialize.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About iShares MSCI Taiwan ETF
EWT tracks the MSCI Taiwan 25/50 Index, providing targeted exposure to large and mid-cap companies in Taiwan. It is heavily concentrated in the information technology sector, serving as a liquid instrument for investors seeking a single-country view of Taiwan's export-oriented and tech-driven economy.
Read more on EWT →About Intuitive Surgical, Inc.
Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed nearly 7,000 da Vinci systems in hospitals worldwide, with more than 4,000 installations in the United States and a growing number in emerging markets.
Read more on ISRG →
